Welcome back everyone to a new season of NeuroPolicy!  We have some great events lined up, and are here to announce our first event of the fall.  We are excited to welcome Dr. Richard Conroy, Director of the Division of Applied Science and Technology, from the National Institute of Biomedical Imaging and Bioengineering, as he discusses recent advances and challenges in brain stimulation technologies and more, in a talk titled:

“Biomodulation without Chemicals”

When: Thursday, October 15th, 2015. 6pm socializing, discussion starts at 6:30pm

Where: AAAS Headquarters, 2nd Floor 1200 New York Ave, NW  (Entrance on 12 & H st)
Room: Revelle

RSVP: https://docs.google.com/forms/d/1O5BeHZxUleAZj8zHA6L6HFF2DggxV1ULV0cCP4zvUXc/viewform?usp=send_form 

Questions: AAASneuropolicy@gmail.com

Bio: Dr. Richard Conroy is the Director of the Division of Applied Science and Technology (DAST) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The focus of the division is to support the development of innovative biomedical imaging technologies that are low cost and accessible, transform our understanding of biological and disease processes, and enable patient centered healthcare. Richard also maintains a small portfolio of grants in hyperspectral and terahertz imaging, clinical informatics tools and comparative effectiveness research. Richard is also a coordinator for the NIH Common Fund program on Single Cell Analysis, the Bridging the Sciences program in collaboration with NSF and the Bioengineering Research Partnership program.

Before joining NIBIB, Dr. Conroy was a researcher in the intramural program of the National Institute of Neurological Disorders and Stroke (NINDS) developing multimodal imaging agents for tracking cells in vivo and methods for characterizing and manipulating individual biomolecules in vitro in collaboration with the National Institute of Standards and Technology (NIST). He has a background in physics, biophysics, biotechnology and international management.